bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

bioAffinity Technologies will present at the American Society for Cell Biology (ASCB) Conference on December 3-7 2022

by Dale Harrison | Dec 1, 2022 | Events

December 1, 2022 bioAffinity Technologies will present at at Cell Bio during the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) Conference bioAffinity reports on a potential therapeutic approach that kills cancer cells...

bioAffinity Technologies will exhibit at the MEGA Lung event as part of the UTSA Health Fair on November 17, 2022

by Dale Harrison | Nov 15, 2022 | Events

November 17, 2022 bioAffinity Technologies will exhibit at the MEGA Lung event as part of the UTSA Health Fair on November 17, 2022.

bioAffinity Technologies will be at the CHEST Conference to Present Results from “Flow Cytometry Analysis of the Lung”

by Dale Harrison | Oct 14, 2022 | Events

October 19, 2022 bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference Powerful platform reveals the lung environment for diagnosing lung diseases Research Scientist Lydia Bederka, PhD, will present results of the...

bioAffinity Technologies Presents its CyPath® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF)

by Dale Harrison | Sep 9, 2022 | Events

September 11-14, 2022 bioAffinity Technologies Presents its CyPath® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF) President and Chief Executive Officer Maria Zannes will speak about bioAffinity Technologies...

bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry

by Dale Harrison | Jul 19, 2022 | Events

July 21, 2022 bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry Senior Vice President William Bauta, Ph.D., will present research leading to development of a product for use with flow cytometry, including its use...

bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection

by Dale Harrison | Apr 25, 2022 | Events

April 28, 2022 bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection Chief Medical and Science Officer and Executive Vice President Vivienne Rebel, MD, PhD, will present at the Cleveland...
« Older Entries
Next Entries »

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (122)
  • Publications (17)

Recent Posts

  • bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics May 28, 2025
  • bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer May 20, 2025
  • bioAffinity Technologies Reports First Quarter 2025 Results May 15, 2025
  • Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer May 8, 2025
  • bioAffinity Technologies Announces Closing of $3.25 Million Offering May 7, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.